SCHEMBL6713073

SCHEMBL6713073

N#Cc1ccc(NC(=O)c2noc3cc(NS(=O)(=O)c4ccc(F)cc4)ccc23)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR27 Q9NS67 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 2/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
ERAP1 Q9NZ08 1/20 0.37
ATIC P31939 2/20 0.37
AVPR2 P30518 1/20 0.37
KDM1A O60341 1/20 0.36
PLA2G7 Q13093 1/20 0.36
ALPL P05186 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
BRD4 O60885 1/20 0.35
ALOX12 P18054 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
PPIA P62937 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710414 0.94 GPR27 (0.40) GPR27MEN1KMT2AALDH1A1KDM4E
SCHEMBL6709849 0.92 GPR27 (0.41) GPR27ALDH1A1KDM4EGLAGAA
SCHEMBL6713533 0.89 HIF1A (0.40) GPR27MEN1KMT2AALDH1A1KDM4E
SCHEMBL6707834 0.89 ALDH1A1 (0.39) GPR27MEN1KMT2AALDH1A1KDM4E
SCHEMBL6713401 0.88 TNIK (0.36) POLBPLA2G7
SCHEMBL6711507 0.87 MEN1 (0.39) GPR27MEN1KMT2AALDH1A1KDM4E
SCHEMBL6707931 0.86 GPR27 (0.41) GPR27MEN1KMT2AALDH1A1POLB
SCHEMBL6919411 0.86 PLA2G7 (0.34) GPR27MEN1KMT2AALDH1A1KDM4E
SCHEMBL6818576 0.84 GPR27 (0.46) GPR27MEN1KMT2AALDH1A1KDM4E
SCHEMBL6708554 0.84 MAP1LC3B (0.37) KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GPR27 1616/4885MEN1 4100/4885KMT2A 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.